Bone and Joint Involvement in Beta Thalassemic Patients: A Cross-sectional Study
- PMID: 39735876
- PMCID: PMC11680515
- DOI: 10.1007/s43465-024-01225-0
Bone and Joint Involvement in Beta Thalassemic Patients: A Cross-sectional Study
Abstract
Purpose: There is paucity of guidelines with inadequate data available about the extent and prevention of bone and joint disease in beta-thalassemic patients in Indian population. This study aims to determine bone and joint involvement in beta-thalassemic patients. It evaluates serum biochemical parameters of bone formation and resorption and correlates with the symptomatology in these patients. The study also determines their daily physical activity and find a correlation if any with bone mineral density.
Methods: The study was carried out on 40 regularly transfused beta thalassemic patients between 5 and 18 years of age under regular follow-up at our centre from June 2012 to June 2014. All patients were interviewed as per a well-structured proforma for symptoms relating to bone and joint disease as described by the patient/parents in past 1 year and physical activity by QAPACE questionnaire. Venous blood samples were drawn under aseptic conditions and used for estimation of biochemical parameters (calcium, phosphorus, alkaline phosphatase, vitamin D, parathyroid hormone and serum ferritin). Enrolled subjects were scanned for bone mineral density (BMD) at femur neck, trochanter and Ward's angle using dual-energy X-ray absorptiometry.
Results: A total of 40 patients were enrolled in the study (Male:Female = 80:20). Half the patients (n = 20) had symptoms pertaining to bone and joint disease. The most common symptom was leg pain (42.50%), followed by backache (22.50%). Asymptomatic patients had greater mean serum vitamin D as compared to the symptomatic patients (22.2 vs 15.08 ng/ml) (p = 0.225). Five patients were detected to have osteopenia, all above 10 years of age. The mean BMD in symptomatic patients at femur neck, trochanter and ward's angle was 0.781, 0.639 and 0.735 g/cm2, respectively, as compared to 0.754, 0.635 and 0.722 g/cm2 in asymptomatic patients. The difference was not statistically significant. Patients with low BMD had lower mean pre-transfusion Hb (< 9 g/dl) (p = 0.01). Eighty percent of osteopenic patients had sedentary lifestyle as compared to 44% of patients with normal BMD. Bone mineral density did not have any correlation with vitamin D levels, serum ferritin and type of chelation therapy.
Conclusion: Pre-transfusion hemoglobin of more than 9 gm/dL has a protective role in maintaining good bone health and bone mineral density. Engaging thalassemia patients in physical activity has a positive effect on bone mineral density. Low vitamin D levels contribute to symptoms of bone and joint involvement in thalassemia and the same needs to be determined and supplemented.
Keywords: Bone mineral density; Osteoporosis; Physical activity; Thalassemia; Vitamin D.
© Indian Orthopaedics Association 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestOn behalf of all authors, the corresponding author state that there is no conflict of interest.
Similar articles
-
Effectiveness and safety of vitamin D in relation to bone health.Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article.
-
Nutritional interventions for survivors of childhood cancer.Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2. Cochrane Database Syst Rev. 2016. PMID: 27545902 Free PMC article.
-
Effect of Iron Overload on Bone Mineral Density in Patients with Transfusion-dependent Thalassemia.J Assoc Physicians India. 2025 Jun;73(6):40-44. doi: 10.59556/japi.73.1029. J Assoc Physicians India. 2025. PMID: 40553589
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials.Hum Reprod Open. 2025 May 13;2025(3):hoaf025. doi: 10.1093/hropen/hoaf025. eCollection 2025. Hum Reprod Open. 2025. PMID: 40575397 Free PMC article.
References
-
- Voskaridou, E., & Terpos, E. (2004). New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. British Journal of Haematology,127(2), 127–139. - PubMed
-
- Karimi, M., Ghiam, A. F., Hashemi, A., Alinejad, S., Soweid, M., & Kashef, S. (2007). Bone mineral density in beta-thalassemia major and intermedia. Indian Pediatrics,44(1), 29–32. - PubMed
-
- Mahachoklertwattana, P., Chuansumrit, A., Sirisriro, R., Choubtum, L., Sriphrapradang, A., & Rajatanavin, R. (2003). Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassaemia disease. Clinical Endocrinology—Oxford,58(3), 273–279. - PubMed
-
- Rund, D., & Rachmilewitz, E. (2005). Beta-thalassemia. New England Journal of Medicine,353(11), 1135–1146. - PubMed
-
- Bielinski, B. K., Darbyshire, P., Mathers, L., Boivin, C. M., & Shaw, N. J. (2001). Bone density in the Asian thalassaemic population: A cross-sectional review. Acta Paediatrica,90(11), 1262–1266. - PubMed
LinkOut - more resources
Miscellaneous